This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at email@example.com or call + 1 (702) 988 2320.
Precision medicine, often known as personalized medicine, is becoming an important aspect of current cancer treatment. It involves adapting treatment to mutations detected in the patient's tumor rather than tailoring treatment to a person's individual genome sequence. Precision medicine in cancer entails analyzing DNA from tumors to find mutations or other genetic abnormalities that cause the cancer. Healthcare professionals may therefore be able to choose a treatment for a specific patient's cancer that best fits, or targets, the tumor DNA alterations. Such treatments are becoming more prominent. Precision medicine already has a significant impact on cancer diagnosis and therapy, and it will become even more so in the future.